AIM Persistence Biopharmaceutical Co., Ltd. is a professional vaccine manufacturer and supplier. We welcome you to obtain Vaccines for More Meningococcal Serotypes from us. Our Xin'er Cong® series products offer multiple serotypes, high seroconversion rates, low residual rates, and a long shelf life. We can provide a stable supply and are a reliable choice for long-term cooperation.
If you are looking for Vaccines for More Meningococcal Serotypes, you can choose AIM Persistence Biopharmaceutical Co.,
Ltd. as your supplier. Our products contain no preservatives or antibiotics, ensuring good safety and making them an
ideal measure for the prevention and control of meningococcal meningitis.
Different countries and regions have experienced relatively obvious changes in the meningococcal microbiota. The
composition of meningococcal cases in group A has generally shown a decreasing trend, while that in group C has first
increased and then decreased. The composition of meningococcal cases in serogroups B, W and other serogroups (including
unclassified groups) has shown an upward trend.
Product Application
Group A and Group A and C polysaccharide vaccines only cover 1-2 types of bacterial communities, have poor immune
effects on infants under 2 years old, and have a relatively short protection period (usually 1-2 years). This
vaccine covers four types of flora, namely A, C, Y and W135. Combined with the process, its immunogenicity has been
enhanced, and the protection period lasts for 3 to 5 years, making it suitable for a wider range of people.
Xin'er Cong® Vaccines for More Meningococcal Serotypes can simultaneously resist the invasion of Neisseria
meningitidis of Group A, Group C, Group Y and Group W135. Whether it is the common domestic cluster A and Cluster C
infections or the increased risk of cluster Y and W135 infections due to cross-border travel and personnel movement,
it can effectively block them. It is especially suitable for people who often go out and travel to meningococcal
epidemic areas (such as the Sahara region in Africa).
Product Advantages
Multiple serotypes: It can prevent meningococcal meningitis caused by the four dominant serogroups
A, C, Y, and W135
High seroconversion rate: The seroconversion rates of antibodies in the four meningococcal
serogroups A, C, Y, and W135 were all over 96%
Long validity period: The only meningococcal product with a validity period of 36 months
Low residue rate: No antibiotics or any preservatives are added during the production process
Hot Tags: Vaccines for More Meningococcal Serotypes, China, Manufacturer, Supplier, Factory
For inquiries about human rabies vaccine, hepatitis B vaccine, hepatitis A vaccine or price list, please leave your email to us and we will be in touch within 24 hours.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.
Privacy Policy